Editor`s Picks

Drugmaker Merck's (NYSE:MRK) stock has outperformed its competitors year to date (ytd), rising 30.6%. Pfizer (NYSE:PFE), which I am bearish on, is down 16.9% so far this year. The Rahway, New...

Stocks often surge in the months after mid-term elections Betting markets show high chance GOP snatches control of House and maybe even Senate Three investment themes that could catch tailwinds in...

Powell says Fed may slow pace of hikes but raise target Economists expect Fed to slow or halt quantitative tightening by mid-2023 Japan maintains low rates and supports yen as it hints at policy...

Technicals indicate a run toward $21 in first leg and $24 in second leg Weakness below $19.40 could trigger drop to $18.45 Silver an inflection point over potential to China’s COVID-Zero After...

Stocks finished the day higher on Monday, following on from Friday’s rally. Yields were higher across the board, and the dollar was again weaker. Still, the S&P was able to generate a 1ish%...

November has been the best month of the year for U.S. stocks counting since 1950 AII investor sentiment has improved—although it remains below the historical average However, 2022 keeps adding...

Share repurchases might be on increase as firms pivot from a new tax in 2023 Management teams appear to be accelerating stock buybacks PKW ETF offers exposure to value and cyclical stocks while...

CPI reading due in China on Tuesday, in the US on Thursday China reiterates commitment to COVID-zero approach US CPI could give timeline on Fed rate pivot Weak number could signal recession From the...